Abstract
The present minireview deals with the use of the oxidative properties of copper(II/I) coordination compounds for valuable applications, namely the selective conversion of alcohols into aldehydes (or ketones), the cleavage of DNA strands (anti-cancer drugs), and the prevention of the formation of copper/amyloid plaques in Alzheimer's disease (AD). The concise report is therefore organized in three clearly defined parts: i) the design and preparation of simple copper(II) (and copper(I)) coordination compounds, mimicking the enzymatic activity of galactose oxidase, to mediate the selective oxidation of alcoholic substrates; ii) the generation of copper-containing chemical nucleases for the development of effective anti-cancer agents; iii) the current state of the art regarding the elucidation of the copper-based biological mechanisms (involving β-amyloid) that govern neural degeneration in AD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
